Please use this identifier to cite or link to this item:
Title: Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
Authors: Bollain y Goytia, Juan José
Arellano Rodríguez, Mariela
Torres del Muro, Felipe de Jesús
Daza Benitez, Leonel
Muñoz Valle, José Francisco
Avalos Díaz, Esperanza del Refugio
Herrera Esparza, Rafael
Issue Date: Nov-2014
Publisher: Hindawi
Abstract: This study was performed to clarify the role of soluble Fas (sFas) in lupus nephritis (LN) and establish a potential relationship between LN and the −670 polymorphism of Fas in 67 patients with systemic lupus erythematosus (SLE), including a subset of 24 LN patients with proteinuria. Additionally, a group of 54 healthy subjects (HS) was included. The allelic frequency of the−670 polymorphism of Fas was determined using PCR-RFLP analysis, and sFas levels were assessed by ELISA. Additionally, the WT-1 protein level in urine was measured. The Fas receptor was determined in biopsies by immunohistochemistry (IHC) and in situ hybridization (FISH) and apoptotic features by TUNEL. Results. The −670 Fas polymorphism showed that the G allele was associated with increased SLE susceptibility, with an odds ratio (OR) of 1.86. The sFas was significantly higher in LN patients with the G/G genotype, and this subgroup exhibited correlations between the sFas level and proteinuria and increased urinary WT1 levels. LN group shows increased expression of Fas and apoptotic features. In conclusion, our results indicate that the G allele of the −670 polymorphism of Fas is associated with genetic susceptibility in SLE patients with elevated levels of sFas in LN with proteinuria.
ISSN: 2090-214X
Other Identifiers: info:eu-repo/semantics/publishedVersion
Appears in Collections:*Documentos Académicos*-- UA Medicina

Files in This Item:
File Description SizeFormat 
Soluble Fas and the −670 Polymorphism.pdf5,95 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons